74.10 +0.32 (0.43%)
Pre-market: 8:53AM EDT
|Bid||74.00 x 800|
|Ask||75.45 x 800|
|Day's range||72.78 - 79.30|
|52-week range||14.80 - 126.90|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||15 Mar 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||108.00|
Investors need to pay close attention to Beam Therapeutics (BEAM) stock based on the movements in the options market lately.
We have highlighted the best ETF of December and its best performing stocks.
The biotech sector is wrapping up a bullish year, with the Biotechnology Index Fund posting a 25% year-to-date return.